Flex Pharma, Inc. 4
4 · Flex Pharma, Inc. · Filed Mar 15, 2016
Insider Transaction Report
Form 4
Wessel Thomas
Chief Medical Officer
Transactions
- Purchase
Common Stock
2016-03-11$7.15/sh+12,000$85,800→ 49,064 total - Purchase
Common Stock
2016-03-14$9.13/sh+8,000$73,040→ 57,064 total
Footnotes (2)
- [F1]The price in Column 4 is a weighted average purchase price. The prices actually received ranged from $6.91 to $7.40. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- [F2]The price in Column 4 is a weighted average purchase price. The prices actually received ranged from $7.69 to $9.58. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.